133 related articles for article (PubMed ID: 21030945)
1. Dueling models in head and neck tumor formation.
Umezawa A; Gorham JD
Lab Invest; 2010 Nov; 90(11):1546-8. PubMed ID: 21030945
[TBL] [Abstract][Full Text] [Related]
2. Tumor-initiating activity and tumor morphology of HNSCC is modulated by interactions between clonal variants within the tumor.
Cameron SR; Dahler AL; Endo-Munoz LB; Jabbar I; Thomas GP; Leo PJ; Poth K; Rickwood D; Guminski A; Saunders NA
Lab Invest; 2010 Nov; 90(11):1594-603. PubMed ID: 20661227
[TBL] [Abstract][Full Text] [Related]
3. Constitutive secretion of Interleukin-4 dictates CD133+ side population cells to resist drug treatment and cell death.
Guan GF; Tang XX; Zhang DJ; Zheng Y; Yu DJ; Zhao Y; Lu YQ; Zhu L
J BUON; 2015; 20(5):1350-9. PubMed ID: 26537085
[TBL] [Abstract][Full Text] [Related]
4. The biology of head and neck cancer stem cells.
Zhang Z; Filho MS; Nör JE
Oral Oncol; 2012 Jan; 48(1):1-9. PubMed ID: 22070916
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cells hypothesis and stem cells in head and neck cancers.
Mannelli G; Gallo O
Cancer Treat Rev; 2012 Aug; 38(5):515-39. PubMed ID: 22197808
[TBL] [Abstract][Full Text] [Related]
6. Elevated tissue factor procoagulant activity in CD133-positive cancer cells.
Milsom C; Anderson GM; Weitz JI; Rak J
J Thromb Haemost; 2007 Dec; 5(12):2550-2. PubMed ID: 17883595
[No Abstract] [Full Text] [Related]
7. Perivascular stem cell niche in head and neck cancer.
Ritchie KE; Nör JE
Cancer Lett; 2013 Sep; 338(1):41-6. PubMed ID: 22842095
[TBL] [Abstract][Full Text] [Related]
8. CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer.
Chen YS; Wu MJ; Huang CY; Lin SC; Chuang TH; Yu CC; Lo JF
PLoS One; 2011; 6(11):e28053. PubMed ID: 22140506
[TBL] [Abstract][Full Text] [Related]
9. Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma.
Harper LJ; Piper K; Common J; Fortune F; Mackenzie IC
J Oral Pathol Med; 2007 Nov; 36(10):594-603. PubMed ID: 17944752
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.
Zhu Z; Hao X; Yan M; Yao M; Ge C; Gu J; Li J
Int J Cancer; 2010 May; 126(9):2067-78. PubMed ID: 19711346
[TBL] [Abstract][Full Text] [Related]
11. Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma.
Yan M; Yang X; Wang L; Clark D; Zuo H; Ye D; Chen W; Zhang P
Mol Cell Proteomics; 2013 Nov; 12(11):3271-84. PubMed ID: 23903875
[TBL] [Abstract][Full Text] [Related]
12. [Progress of cancer stem cells of solid tumor].
Ni XG; Zhao P
Ai Zheng; 2006 Jun; 25(6):775-8. PubMed ID: 16764780
[TBL] [Abstract][Full Text] [Related]
13. Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma.
Zhang Y; Sun B; Zhao X; Liu Z; Wang X; Yao X; Dong X; Chi J
J Surg Oncol; 2013 Nov; 108(6):414-9. PubMed ID: 23996537
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance.
Athanassiou-Papaefthymiou M; Shkeir O; Kim D; Divi V; Matossian M; Owen JH; Czerwinski MJ; Papagerakis P; McHugh J; Bradford CR; Carey TE; Wolf GT; Prince ME; Papagerakis S
Int J Immunopathol Pharmacol; 2014; 27(3):337-49. PubMed ID: 25280025
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypes.
Schmitt F; Ricardo S; Vieira AF; Dionísio MR; Paredes J
Virchows Arch; 2012 Jun; 460(6):545-53. PubMed ID: 22562130
[TBL] [Abstract][Full Text] [Related]
16. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.
Chen YW; Chen KH; Huang PI; Chen YC; Chiou GY; Lo WL; Tseng LM; Hsu HS; Chang KW; Chiou SH
Mol Cancer Ther; 2010 Nov; 9(11):2879-92. PubMed ID: 21062915
[TBL] [Abstract][Full Text] [Related]
17. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biological significance of stem-like CD133(+)CXCR4(+) cells in esophageal squamous cell carcinoma.
Lu C; Xu F; Gu J; Yuan Y; Zhao G; Yu X; Ge D
J Thorac Cardiovasc Surg; 2015 Aug; 150(2):386-95. PubMed ID: 26092504
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
Lo WL; Yu CC; Chiou GY; Chen YW; Huang PI; Chien CS; Tseng LM; Chu PY; Lu KH; Chang KW; Kao SY; Chiou SH
J Pathol; 2011 Mar; 223(4):482-95. PubMed ID: 21294122
[TBL] [Abstract][Full Text] [Related]
20. Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.
Verneuil L; Leboeuf C; Bousquet G; Brugiere C; Elbouchtaoui M; Plassa LF; Peraldi MN; Lebbé C; Ratajczak P; Janin A
Oncotarget; 2015 Dec; 6(39):41497-507. PubMed ID: 26594799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
